Yatharth Hospital & Trauma Care Services Ltd
Incorporated in 2008, Yatharth Hospital and Trauma Care Services Limited is a multi-care hospitals at Noida, Greater Noida, and Noida Extension, Uttar Pradesh.[1]
- Market Cap ₹ 6,524 Cr.
- Current Price ₹ 677
- High / Low ₹ 844 / 345
- Stock P/E 39.0
- Book Value ₹ 175
- Dividend Yield 0.00 %
- ROCE 14.0 %
- ROE 10.4 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 152% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -5.84%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE Healthcare BSE Allcap Nifty Microcap 250 Nifty Total Market
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| 71 | 78 | 91 | 136 | 215 | 375 | 478 | 635 | 860 | 1,089 | |
| 53 | 60 | 71 | 98 | 147 | 263 | 343 | 453 | 635 | 829 | |
| Operating Profit | 18 | 18 | 20 | 38 | 68 | 112 | 135 | 182 | 225 | 260 |
| OPM % | 25% | 24% | 22% | 28% | 32% | 30% | 28% | 29% | 26% | 24% |
| 0 | 0 | 0 | 0 | 1 | 2 | 3 | 16 | 16 | 32 | |
| Interest | 6 | 5 | 7 | 20 | 20 | 23 | 23 | 11 | 12 | 2 |
| Depreciation | 7 | 6 | 8 | 21 | 21 | 28 | 28 | 29 | 57 | 71 |
| Profit before tax | 5 | 8 | 5 | -2 | 28 | 63 | 88 | 157 | 172 | 219 |
| Tax % | 41% | 23% | 21% | -18% | 30% | 30% | 25% | 27% | 24% | |
| 3 | 6 | 4 | -2 | 20 | 44 | 66 | 114 | 131 | 165 | |
| EPS in Rs | 2.21 | 3.75 | 2.43 | -0.79 | 11.09 | 6.74 | 10.04 | 13.33 | 13.55 | 17.37 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 45% |
| 3 Years: | 32% |
| TTM: | 32% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 152% |
| 3 Years: | 43% |
| TTM: | 29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 63% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 18% |
| 3 Years: | 16% |
| Last Year: | 10% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 16 | 16 | 16 | 16 | 66 | 66 | 86 | 96 | 96 |
| Reserves | 29 | 41 | 39 | 38 | 56 | 51 | 117 | 788 | 1,509 | 1,592 |
| 85 | 125 | 175 | 194 | 193 | 264 | 267 | 85 | 12 | 26 | |
| 10 | 11 | 26 | 39 | 43 | 45 | 36 | 60 | 114 | 141 | |
| Total Liabilities | 138 | 193 | 257 | 287 | 309 | 426 | 486 | 1,019 | 1,731 | 1,856 |
| 54 | 53 | 164 | 189 | 251 | 303 | 299 | 442 | 605 | 852 | |
| CWIP | 64 | 110 | 65 | 62 | 0 | 0 | 0 | 0 | 222 | 110 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 74 | 21 |
| 20 | 30 | 27 | 36 | 58 | 123 | 187 | 577 | 829 | 873 | |
| Total Assets | 138 | 193 | 257 | 287 | 309 | 426 | 486 | 1,019 | 1,731 | 1,856 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| 25 | 17 | 17 | 39 | 44 | 60 | 64 | -3 | 150 | |
| -50 | -51 | -78 | -43 | -21 | -52 | -20 | -226 | -420 | |
| 26 | 43 | 47 | 5 | -19 | -1 | -18 | 304 | 520 | |
| Net Cash Flow | 1 | 9 | -13 | 1 | 3 | 7 | 26 | 75 | 249 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 58 | 44 | 48 | 45 | 62 | 83 | 82 | 131 | 128 |
| Inventory Days | 47 | 42 | 88 | 72 | |||||
| Days Payable | 127 | 106 | 490 | 347 | |||||
| Cash Conversion Cycle | -22 | -20 | -354 | -229 | 62 | 83 | 82 | 131 | 128 |
| Working Capital Days | 44 | 29 | -75 | -89 | -18 | 0 | 29 | 118 | 109 |
| ROCE % | 8% | 6% | 7% | 18% | 26% | 27% | 24% | 14% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
6 Feb - Q3 FY26 earnings call audio recorded Feb 6, 2026 available on company website.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
6 Feb - Newspaper Publication of Financial Results - Q3 FY26.
- Announcement under Regulation 30 (LODR)-Investor Presentation 5 Feb
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
5 Feb - Q3 FY26: Revenue Rs.3,205mn (+46%); PAT Rs.431mn (+41%); new hospitals contributed 9%.
- Unaudited Financial Results For Q3 FY26 5 Feb
Annual reports
Concalls
-
Feb 2026TranscriptAI SummaryPPT REC
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
Jun 2025Transcript PPT
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT
-
Nov 2024TranscriptAI SummaryPPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023TranscriptPPT
-
Nov 2023Transcript PPT
-
Nov 2023TranscriptAI SummaryPPT
-
Aug 2023Transcript PPT
Hospital Portfolio:[1]
Yatharth operates a network of multi-specialty and super-specialty hospitals primarily in North India, focusing on tertiary care, trauma services, and advanced treatments. As of September 2025, the portfolio includes 7 hospitals with a bed capacity exceeding 2,300 beds.